Top news of the week: 04.10.2022.
New nasal spray vaccines might reduce COVID infections, but the money is still missing
New nasal spray vaccines might reduce COVID infections and cut-off transmission, but data supporting the approach, and funding for clinical trials, is scant.
NC and Texas Biopharma Hubs Grow as Companies Look Beyond Boston & California
Biopharma companies are expanding beyond the traditional confines of Massachusetts and California with hubs forming – most notably – in the South and Southeast.
A Flagship cell therapy startup secures $120M in new funding
Cellarity is the second Flagship company in as many months to raise a Series C round instead of filing to go public.
UT-Arlington Creates Training Program for Jobs in Biomanufacturing and Biotechnology
Seven major North Texas health care employers have already committed to hiring 1,100 entry-level biotech workers.
Sudo joins a wave of startups taking aim at Bristol Myers’ new skin disease drug
The startup, which emerged Wednesday with $37 million in funding, is the latest company trying to top Bristol Myers’ TYK2 inhibitor Sotyktu.
Vir Biotechnology Awarded U.S. Government Contract to Support Pandemic Preparedness for Influenza and Other Infectious Disease Threats
– First award from the agency’s solicitation for contracts for Pre-Exposure Prophylaxis for Influenza – – Initial investment of approximately $55 million from Biomedical Advanced Research ...
Biotech Meliora Therapeutics Gets $11 Million Seed Financing for Cancer Treatments
Some 97% of cancer drugs fail in clinical trials. Using machine-learning and gene-editing, Meliora plans to delve into how the drugs work in hopes of creating ones with better odds of ...
Former Spark CEO Marrazzo joins epigenetics startup’s board
Chroma Medicine, which launched last year with $125 million in funding, has drawn several high-profile biotech leaders to it, including ex-Alnylam CEO John Maraganore and deal maven George ...